Under the terms of the deal, Sanofi will pay $600 million upfront to buy an affiliate of the California-based biotech, called ...
GlobalData on MSN8h
Sanofi outlays $1.9bn to purchase Dren Bio’s bispecific antibodySanofi’s move for Dren Bio’s clinical asset boosts its immunology-focused strategy of becoming a leader in the field.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback